S.252
An act relating to stem cell therapies not approved by the U.S. Food and Drug Administration
Sponsors:
Sen. Virginia Lyons
Last Recorded Action: 9/11/2020 - Recommitted to Committee on Health and Welfare on motion of Senator Ashe
Committee Activity - Witnesses Who Testified
Regular Session 2019-2020
Senate Committee on Health and Welfare
- Jessa Barnard, Executive Director, Vermont Medical Society
- Cindy Bruzzese, Director, Vermont Ethics Network
- Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- Charity Clark, Chief of Staff, Attorney General's Office
- Jonathon Fenton, Vermont Regenerative Medicine
- David Herlihy, Director of Hospital Licensing, Department of Health, Executive Director, Vermont Board of Medical Practice
- Lauren Hibbert, Director, Office of Professional Regulation, Office of the Secretary of State
- Shayla Livingston, Public Health Policy Advisor, Department of Health
- Daniel Weiss, Professor of Medicine, Professor of Cell and Molecular Biology, University of Vermont